Orexo AB (publ) ORX.ST Stock
21.6 SEK
{{ price }}
1.647061%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
744.11M SEK
LOW - HIGH [24H]
20.95
-
21.75 SEK
VOLUME [24H]
11.42K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-2.13 SEK
Orexo AB (publ) Price Chart
Orexo AB (publ) ORX.ST Financial and Trading Overview
| Orexo AB (publ) stock price | 21.6 SEK |
| Previous Close | 9.45 SEK |
| Open | 9.45 SEK |
| Bid | 9.33 SEK x 0 |
| Ask | 9.44 SEK x 0 |
| Day's Range | 9.29 - 9.45 SEK |
| 52 Week Range | 8.49 - 34.3 SEK |
| Volume | 1.79K SEK |
| Avg. Volume | 41.13K SEK |
| Market Cap | 329.84M SEK |
| Beta (5Y Monthly) | 0.605747 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.13 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 38 SEK |
ORX.ST Valuation Measures
| Enterprise Value | 570.78M SEK |
| Trailing P/E | N/A |
| Forward P/E | -2.464752 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.5288489 |
| Price/Book (mrq) | 2.5133119 |
| Enterprise Value/Revenue | 0.915 |
| Enterprise Value/EBITDA | -4.866 |
Trading Information
Orexo AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.605747 |
| 52-Week Change | -55.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 34.3 SEK |
| 52 Week Low | 8.49 SEK |
| 50-Day Moving Average | 11.94 SEK |
| 200-Day Moving Average | 17.08 SEK |
ORX.ST Share Statistics
| Avg. Volume (3 month) | 41.13K SEK |
| Avg. Daily Volume (10-Days) | 64.22K SEK |
| Shares Outstanding | 34.37M |
| Float | 21.62M |
| Short Ratio | N/A |
| % Held by Insiders | 17.29% |
| % Held by Institutions | 41.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -34.93% |
| Operating Margin (ttm) | -25.58% |
| Gross Margin | 83.35% |
| EBITDA Margin | -18.80% |
Management Effectiveness
| Return on Assets (ttm) | -9.25% |
| Return on Equity (ttm) | -95.028% |
Income Statement
| Revenue (ttm) | 623.7M SEK |
| Revenue Per Share (ttm) | 18.15 SEK |
| Quarterly Revenue Growth (yoy) | -0.40% |
| Gross Profit (ttm) | 521.7M SEK |
| EBITDA | -117300000 SEK |
| Net Income Avi to Common (ttm) | -217900000 SEK |
| Diluted EPS (ttm) | -6.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 278.9M SEK |
| Total Cash Per Share (mrq) | 8.12 SEK |
| Total Debt (mrq) | 530.4M SEK |
| Total Debt/Equity (mrq) | 410.84 SEK |
| Current Ratio (mrq) | 1.928 |
| Book Value Per Share (mrq) | 3.756 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -156600000 SEK |
| Levered Free Cash Flow (ttm) | -36525000 SEK |
Profile of Orexo AB (publ)
| Country | Sweden |
| State | N/A |
| City | Uppsala |
| Address | Rapsgatan 7E |
| ZIP | N/A |
| Phone | 46 1 87 80 88 00 |
| Website | https://www.orexo.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 122 |
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is also developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.
Q&A For Orexo AB (publ) Stock
What is a current ORX.ST stock price?
Orexo AB (publ) ORX.ST stock price today per share is 21.6 SEK.
How to purchase Orexo AB (publ) stock?
You can buy ORX.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orexo AB (publ)?
The stock symbol or ticker of Orexo AB (publ) is ORX.ST.
Which industry does the Orexo AB (publ) company belong to?
The Orexo AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does Orexo AB (publ) have in circulation?
The max supply of Orexo AB (publ) shares is 34.45M.
What is Orexo AB (publ) Price to Earnings Ratio (PE Ratio)?
Orexo AB (publ) PE Ratio is now.
What was Orexo AB (publ) earnings per share over the trailing 12 months (TTM)?
Orexo AB (publ) EPS is -2.13 SEK over the trailing 12 months.
Which sector does the Orexo AB (publ) company belong to?
The Orexo AB (publ) sector is Healthcare.
Orexo AB (publ) ORX.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2732.06 SEK 266.68 USD |
-1.5
|
— — | 2732.06 SEK 266.68 USD | 2771.68 SEK 270.55 USD | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4524.33 SEK 441.63 USD |
-1
|
— — | 4524.33 SEK 441.63 USD | 4581.2 SEK 447.18 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 7565.06 SEK 738.44 USD |
-0.81
|
— — | 7565.06 SEK 738.44 USD | 7565.06 SEK 738.44 USD | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 636.84 SEK 62.16 USD |
+0.59
|
— — | 633.21 SEK 61.81 USD | 638.3 SEK 62.31 USD | — - | — — |
| OMX Stockholm_GI OMXSGI | 487.13 SEK 47.55 USD |
-1.49
|
— — | 487.13 SEK 47.55 USD | 493.17 SEK 48.14 USD | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 452.77 SEK 44.2 USD |
+0.24
|
— — | 451.78 SEK 44.1 USD | 453.92 SEK 44.31 USD | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 365.72 EUR 399.78 USD |
-0.2
|
— — | 365.63 EUR 399.69 USD | 366.81 EUR 400.97 USD | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 956.49 SEK 93.37 USD |
-1.49
|
— — | 956.49 SEK 93.37 USD | 968.23 SEK 94.51 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4397.78 SEK 429.28 USD |
-1.5
|
— — | 4397.78 SEK 429.28 USD | 4461.56 SEK 435.5 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3511.58 SEK 342.77 USD |
-1
|
— — | 3511.58 SEK 342.77 USD | 3555.71 SEK 347.08 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5573.44 SEK 544.04 USD |
-0.81
|
— — | 5573.44 SEK 544.04 USD | 5573.44 SEK 544.04 USD | — - | — — |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1262.91 SEK 123.28 USD |
+0.59
|
— — | 1255.7 SEK 122.57 USD | 1265.8 SEK 123.56 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 980.59 SEK 95.72 USD |
-1.49
|
— — | 980.59 SEK 95.72 USD | 992.75 SEK 96.9 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 477.13 SEK 46.57 USD |
-1.49
|
— — | 477.13 SEK 46.57 USD | 483.05 SEK 47.15 USD | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 538.42 ISK 3.96 USD |
-0.06
|
— — | 537.03 ISK 3.95 USD | 539.51 ISK 3.97 USD | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 365.88 DKK 53.65 USD |
-0.2
|
— — | 365.8 DKK 53.63 USD | 366.99 DKK 53.81 USD | — - | — — |
- {{ link.label }} {{link}}